Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01687985 · ClinicalTrials.gov registry record · Phase 2
A Safety and Efficacy Evaluation of BLI801 Laxative in Constipated Adults
A Phase 2 study, sponsored by Braintree Laboratories.
- Completed
- Registry status
- Phase 2
- Development phase
- 81
- Enrollment target
NCT01687985: Completed Phase 2 study, sponsored by Braintree Laboratories.
NCT01687985 is a Phase 2 study that has completed, run by Braintree Laboratories. The registered enrollment target is 81 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (39% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01687985, a Phase 2 study, has completed, sponsored by Braintree Laboratories.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 81 participants
- Enrollment target
Study Summary
A pilot study to evaluate the safety and efficacy of multiple BLI801 doses in constipated adults.
Primary Outcome
percent of patients experiencing a response in 3 out of 4 weeks of treatment
Interventions
- DRUG BLI801 laxative - low dose
- DRUG BLI801 laxative - high dose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2012-08 |
| Est. Completion | 2013-03 |
| Phase | Phase 2 |
What the finished NCT01687985 record still lists
NCT01687985 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 81 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (39% lower).
The record links to 0 conditions, and to 2 interventions - of which BLI801 laxative - low dose is the first listed.
NCT01687985 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01687985 about?
NCT01687985 is a clinical study titled "A Safety and Efficacy Evaluation of BLI801 Laxative in Constipated Adults". A pilot study to evaluate the safety and efficacy of multiple BLI801 doses in constipated adults.
What is the current status of trial NCT01687985?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 81 participants. The study started on 2012-08. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01687985?
The interventions under investigation include: BLI801 laxative - low dose (DRUG), BLI801 laxative - high dose (DRUG).
Who is sponsoring clinical trial NCT01687985?
This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01687985's enrollment target sits among peer trials
81 834th of 2000 higher than 1,159 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia